Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

M3W5M8 (M3W5M8_FELCA) Felis catus (Cat) (Felis silvestris catus)

Pre-mRNA processing factor 8 UniProtKBInterProSTRINGInteractive Modelling

2335 aa; Sequence (Fasta) ; 88 identical sequences

Available Structures

65 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
The cryo-EM structure of human C* complex Heteromer
O15234; O43660; O60306; O60508; O75643; O75934; O95391; O95926; P08579; P09661; P14678; P38919; P41223; P61326; P62304; P62306; P62308; P62314; P62316; P62318; Q13573; Q14562; Q15029; Q6P2Q9; Q8N5F7; Q8WUQ7; Q96DI7; Q99459; Q9BZJ0; Q9H875; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y3C6; Q9Y421; Q9Y5S9;
25-2335
IHP;GTP;MG;ZN;ATP;
Assess
Structure of the human U5.U4/U6 tri-snRNP at 2.9A resolution. Heteromer
O43172; O43290; O43395; O75643; O94906; O95777; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q15029; Q53GS9; Q6P2Q9; Q8WVK2; Q8WWY3; Q96DI7; Q9BTD8; Q9BUQ8; Q9UK45; Q9Y333; Q9Y4Y9; Q9Y4Z0;
25-2335
IHP;MG;GTP;ZN;
Assess
Human post-catalytic P complex spliceosome Heteromer
O43660; O60306; O60508; O75643; O75934; O95391; O95926; P08579; P09661; P14678; P38919; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q13573; Q14562; Q15029; Q6IQ49; Q6P2Q9; Q8N5F7; Q8WUQ7; Q96A72; Q96DI7; Q99459; Q9BZJ0; Q9H875; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UQ35; Q9Y3C6; Q9Y421; Q9Y5S9;
25-2335
MG;K;ATP;GTP;ZN;IHP;
Assess
Cryo-EM Structure of the human minor pre-B complex (pre-precatalytic spliceosome) U11 and tri-snRNP… Heteromer
O43172; O43290; O43395; O75643; O94906; P14678; P55769; P62304; P62306; P62308; P62314; P62316; P62318; Q13523; Q15029; Q16560; Q53GS9; Q6IEG0; Q6P2Q9; Q86UT8; Q8N8D1; Q8WWY3; Q96DI7; Q9BUQ8; Q9BV90; Q9NX01; Q9UDW3;
25-2335
MG;IHP;GTP;ZN;
Assess
Cryo-EM structure of a human post-catalytic spliceosome (P complex) at 3.0 angstrom Heteromer
O15234; O43660; O60306; O60508; O75643; O75934; O95391; O95926; P08579; P09661; P14678; P38919; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q13573; Q14562; Q15029; Q6P2Q9; Q96A72; Q96DI7; Q99459; Q9BZJ0; Q9H875; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y3C6; Q9Y5S9;
25-2335
IHP;GTP;MG;ZN;ATP;
Assess
Cryo-EM structure of the human spliceosome just prior to exon ligation at 3.6 angstrom Heteromer
O15234; O43660; O60306; O60508; O75643; O75934; O95391; O95926; P08579; P09661; P14678; P38919; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q13573; Q14562; Q15029; Q6P2Q9; Q96A72; Q96DI7; Q99459; Q9BZJ0; Q9H875; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UQ35; Q9Y3C6; Q9Y5S9;
25-2335
IHP;GTP; 11×MG;ADP;ZN;ATP;
Assess
The Cryo-EM Structure of Human Catalytic Step I Spliceosome (C complex) at 4.1 angstrom resolution Heteromer
O15234; O43660; O60306; O60508; O75643; O75934; O95926; P08579; P09661; P14678; P38919; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q13427; Q13573; Q15029; Q6P2Q9; Q92620; Q96A72; Q96BP3; Q96DI7; Q99459; Q9BW85; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9NXE8; Q9P013; Q9ULR0; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y3C6; Q9Y5S9;
25-2335
IHP;GTP;MG;ADP;ZN;ATP;
Assess
Cryo-EM structure of a human activated spliceosome (early Bact) at 4.9 angstrom. Heteromer
O15541; O43660; O60231; O75533; O75643; P08579; P09661; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q6UX04; Q7RTV0; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9P013; Q9Y388; Q9Y3B4;
25-2335
IHP;GTP;MG;ZN;
Assess
cryo-EM structure of a human activated spliceosome (mature Bact) at 5.1 angstrom. Heteromer
O15541; O43660; O60231; O60306; O60508; O75533; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q6UX04; Q7RTV0; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y388; Q9Y3B4; Q9Y3C6;
25-2335
IHP;GTP;MG; 13×ZN;
Assess
Cryo-EM structure of the human activated spliceosome (late Bact) at 6.5 angstrom Heteromer
O43660; O60231; O60306; O60508; O75533; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y388; Q9Y3B4; Q9Y3C6;
25-2335
IHP;ALA;GTP;MG; 10×ZN;
Assess
Cryo-EM Structure of the Activated Human Minor Spliceosome (minor Bact Complex) Heteromer
O15541; O43660; O60231; O75533; O75643; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q13356; Q13435; Q13573; Q15029; Q15393; Q15427; Q5RL73; Q6P2Q9; Q6UX04; Q7RTV0; Q8IYB3; Q8TAD8; Q92917; Q96DI7; Q99459; Q9BRD0; Q9BWG6; Q9BWJ5; Q9BZJ0; Q9H6L4; Q9HCG8; Q9P013; Q9P021; Q9UQ35; Q9Y388; Q9Y3B4;
27-2335
IHP;GTP;MG;K;G5J;ZN;
Assess
human Bact spliceosome core structure Heteromer
O15541; O43660; O60508; O75533; P41223; Q13435; Q13573; Q15029; Q15393; Q15428; Q6P2Q9; Q6UX04; Q7RTV0; Q8IYB3; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9NW64; Q9P013; Q9UQ35; Q9Y388; Q9Y3B4; Q9Y3C6;
26-2316
MG;IHP;GTP; 10×ZN;
Assess
human Bact spliceosome core structure Heteromer
O15541; O43660; O60231; O60306; O60508; O75533; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q13573; Q15029; Q15393; Q15428; Q15459; Q6P2Q9; Q6UX04; Q7RTV0; Q8IYB3; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9ULR0; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y388; Q9Y3B4; Q9Y3C6;
26-2316
11×ZN;MG;IHP;GTP;ADP;
Assess
3D structure determination of the human*U4/U6.U5* tri-snRNP complex Heteromer
O43172; O43395; O75643; O94906; O95777; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q15029; Q53GS9; Q6P2Q9; Q8WWY3; Q96DI7; Q9BUQ8; Q9UK45; Q9Y333; Q9Y4Y9; Q9Y4Z0;
26-2314
Assess
The Cryo-EM Structure of the Precusor of Human Pre-catalytic Spliceosome (pre-B complex) Heteromer
O43172; O43395; O75533; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q15029; Q15393; Q15427; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WWY3; Q96DI7; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
56-2335
IHP;GTP;MG;
Assess
Structure of the human 20S U5 snRNP Heteromer
O75643; O94906; O95400; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q15029; Q6P2Q9; Q96DI7; Q9BUQ8;
58-2335
GTP;
Assess
Human pre-Bact-1 spliceosome Heteromer
O14776; O43660; O75533; O75643; O95777; P08579; P09661; P14678; P41223; P52298; P55081; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; Q07955; Q09161; Q12874; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8IYB3; Q8NAV1; Q8TAD8; Q96DI7; Q96NC0; Q99459; Q9BWJ5; Q9BZL1; Q9NW64; Q9P013; Q9UK45; Q9Y2W2; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
63-2335
IHP;GTP;MG;GTG;
Assess
Structure of a late-stage activated spliceosome (BAqr) arrested with a dominant-negative Aquarius m… Heteromer
O15541; O43660; O60231; O60306; O60508; O75533; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8WUA2; Q92917; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9ULR0; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y3C6;
53-2316
12×ZN;IHP;GTP;MG;
Assess
cryo-EM structure of the human spliceosomal B complex protomer (tri-snRNP core region) Heteromer
O14776; O43172; O43290; O43395; O75554; O94906; P41223; P55081; P55769; P83876; Q15029; Q15459; Q6P2Q9; Q8NAV1; Q8WWY3; Q96NC0; Q9BZL1;
58-2316
Assess
Cryo-EM structure of a pre-catalytic human spliceosome primed for activation (B complex) Heteromer
O43172; O43290; O43395; O43447; O75533; O75554; O75643; O94906; O95777; P08579; P09661; P14678; P55081; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q13123; Q15029; Q15393; Q2TAY7; Q6P2Q9; Q7RTV0; Q8NAV1; Q8WWY3; Q96DI7; Q96NC0; Q9BWJ5; Q9UK45; Q9Y333; Q9Y4Y9; Q9Y4Z0;
63-2319
Assess
Human pre-Bact-2 spliceosome Heteromer
O43660; O60306; O60508; O60870; O75533; O75643; P08579; P09661; P14678; P41223; P55081; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8IYB3; Q8NAV1; Q8TAD8; Q8WYA6; Q96DI7; Q96NC0; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9BZL1; Q9HCS7; Q9NW64; Q9P013; Q9UNP9; Q9Y388; Q9Y3B4;
63-2318
GTP;MG;IHP;
Assess
The cryo-EM structure of human pre-C*-II complex Heteromer
O15234; O43660; O60306; O60508; O75934; O95391; O95926; P08579; P09661; P14678; P38919; P41223; P61326; P62304; P62306; P62308; P62314; P62316; P62318; Q13573; Q14562; Q15029; Q6P2Q9; Q8WUQ7; Q96DI7; Q99459; Q9BZJ0; Q9GZU8; Q9H875; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y3C6; Q9Y421; Q9Y5S9;
25-2015
IHP;GTP;MG;ZN;ATP;
Assess
Cryo-EM structure of a human intron lariat spliceosome after Prp43 loaded (ILS2 complex) at 2.9 ang… Heteromer
O43143; O43660; O60306; O60508; O75934; O95926; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q13573; Q15029; Q2TBE0; Q6P2Q9; Q96DI7; Q99459; Q9BZJ0; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UNP9; Q9Y3C6;
25-2015
IHP;GTP;MG;ZN;
Assess
Cryo-EM structure of a human intron lariat spliceosome prior to Prp43 loaded (ILS1 complex) at 2.9 … Heteromer
O43660; O60306; O60508; O75934; O95926; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q13573; Q15029; Q2TBE0; Q6P2Q9; Q96DI7; Q99459; Q9BZJ0; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UNP9; Q9Y3C6;
25-2015
IHP;GTP;MG;ZN;
Assess
The cryo-EM structure of human pre-C*-I complex Heteromer
O15234; O43660; O60306; O60508; O75934; O95926; P08579; P09661; P14678; P38919; P41223; P61326; P62304; P62306; P62308; P62314; P62316; P62318; Q13573; Q14562; Q15029; Q6P2Q9; Q96DI7; Q99459; Q9BZJ0; Q9GZU8; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y3C6; Q9Y5S9;
25-2015
IHP;GTP;MG;ZN;ATP;
Assess
Cryo-EM structure of a human spliceosome activated for step 2 of splicing (C* complex) Heteromer
O43660; O60306; O60508; O75934; O95926; P08579; P09661; P14678; P38919; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q13573; Q14562; Q15029; Q6P2Q9; Q96DI7; Q99459; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y3C6;
26-1990
Assess
Structural organization of a late activated human spliceosome (Baqr, core region) Heteromer
O15541; O43660; O60231; O75533; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q6P2Q9; Q7RTV0; Q8WUA2; Q92917; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9NW64; Q9P013; Q9UQ35; Q9Y3C6;
53-2016
12×ZN;IHP;GTP;MG;
Assess
Human C Complex Spliceosome - High-resolution CORE Heteromer
O43660; O60508; P41223; Q13573; Q14331; Q15029; Q6P2Q9; Q86X95; Q92620; Q96DI7; Q99459; Q9BW85; Q9BZJ0; Q9HCG8; Q9NW64; Q9NW82; Q9NXE8; Q9P013; Q9ULR0; Q9UQ35; Q9Y3C6;
26-1755
MG;IHP;GTP;ZN;
Assess
Structure of the human 20S U5 snRNP core Heteromer
O75643; O94906; O95400; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q15029; Q6P2Q9; Q9BUQ8;
58-1754
GTP;
Assess
Human pre-Bact-1 spliceosome core structure Heteromer
O14776; O43660; P41223; P55081; Q13573; Q15029; Q6P2Q9; Q8NAV1; Q96NC0; Q9BZL1; Q9P013; Q9Y2W2;
63-1755
IHP;GTP;MG;
Assess
Human pre-Bact-2 spliceosome core structure Heteromer
O43660; O60508; P41223; P55081; Q13573; Q15029; Q6P2Q9; Q8NAV1; Q96NC0; Q99459; Q9BZL1; Q9NW64; Q9P013;
63-1755
GTP;MG;KGN;
Assess
Human C Complex Spliceosome - Medium-resolution PERIPHERY Heteromer
O60306; O60508; O75643; O75934; O95926; P08579; P09661; P14678; P38919; P61326; P62304; P62306; P62308; P62314; P62316; P62318; Q13573; Q14331; Q6P2Q9; Q92620; Q96BP3; Q99459; Q9BW85; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9NW82; Q9ULR0; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y5S9;
1756-2316
Assess
Crystal structure of human Brr2 in complex with the Prp8 Jab1/MPN domain Heteromer
O75643; Q6P2Q9;
2067-2335
ADP;MG;
Assess
Cryo-EM structure of Brr2 in complex with Jab1/MPN and C9ORF78 Heteromer
O75643; Q6P2Q9; Q9NZ63;
2070-2335
Assess
Human Brr2 Helicase Region in complex with C-tail deleted Jab1 and compound 76 Heteromer
O75643; Q6P2Q9;
2064-2320
B09; 12×EDO;
Assess
Human Brr2 Helicase Region in complex with C-tail deleted Jab1 and compound 24 Heteromer
O75643; Q6P2Q9;
2064-2320
A09; 11×EDO;
Assess
Crystal structure of the human spliceosomal maturation factor AAR2 bound to the RNAse H domain of P… Heteromer
Q6P2Q9; Q9Y312;
1758-2014
Assess
Human Brr2 Helicase Region in complex with C-tail deleted Jab1 and compound 39 Heteromer
O75643; Q6P2Q9;
2064-2320
QAU; 10×EDO;
Assess
Human Brr2 Helicase Region in complex with C-tail deleted Jab1 and compound 34 Heteromer
O75643; Q6P2Q9;
2064-2320
16×EDO;SAN;
Assess
Human Brr2 Helicase Region in complex with C-tail deleted Jab1 and compound 18 Heteromer
O75643; Q6P2Q9;
2064-2320
QB6; 16×EDO;
Assess
Human Brr2 Helicase Region in complex with C-tail deleted Jab1 and compound 86 Heteromer
O75643; Q6P2Q9;
2064-2320
Q9I;EDO;
Assess
Human Brr2 Helicase Region in complex with C-tail deleted Jab1 Heteromer
O75643; Q6P2Q9;
2064-2320
SO4;
Assess
Human Brr2 Helicase Region in complex with C-tail deleted Jab1 and compound 78 Heteromer
O75643; Q6P2Q9;
2064-2320
10×EDO;Q8Z;
Assess
Human Brr2 Helicase Region in complex with C-tail deleted Jab1 and ADP Heteromer
O75643; Q6P2Q9;
2064-2320
ADP;MG;
Assess
Human Brr2 Helicase Region in complex with C-tail deleted Jab1 and mant-ATPgammaS Heteromer
O75643; Q6P2Q9;
2064-2320
TGB;MG;
Assess
Human Brr2 Helicase Region D534C/N1866C in complex with C-tail deleted Jab1 Heteromer
O75643; Q6P2Q9;
2064-2320
Assess
Human Brr2 Helicase Region in complex with C-tail deleted Jab1 and mant-ADP Heteromer
O75643; Q6P2Q9;
2064-2320
TG8;MG;
Assess
Human Brr2 Helicase Region in complex with C-tail deleted Jab1 and ATPgammaS Heteromer
O75643; Q6P2Q9;
2064-2320
AGS;MG;
Assess
Human Brr2 Helicase Region in complex with C-tail deleted Jab1 and compound 26 Heteromer
O75643; Q6P2Q9;
2064-2320
Q96;EDO;GOL;
Assess
Human Brr2 Helicase Region in complex with C-tail deleted Jab1 and compound 50 Heteromer
O75643; Q6P2Q9;
2064-2320
QB0;
Assess
Structure of U5 snRNP assembly and recycling factor TSSC4 in complex with BRR2 and Jab1 domain of P… Heteromer
O75643; Q6P2Q9; Q9Y5U2;
2071-2320
Assess
hPRP8 Non-Native Subdomainhomo-2-mer1831-1990
Assess
Crystal Structure of Human Prp8, Residues 1755-2016monomer1760-2016
NA;CL;
Assess
Open and closed forms of V1788D human PRP8 RNase H-like domain with bound Mg ionmonomer1770-1990
GOL;CL;
Assess
Open and closed forms of wild-type human PRP8 RNase H-like domain with bound Mg ionmonomer1770-1990
GOL;CL;
Assess
Open and closed forms of D1781E human PRP8 RNase H-like domain with bound Mg ionmonomer1770-1990
CL;GOL;
Assess
Open and closed forms of T1791P+R1865A human PRP8 RNase H-like domain with bound Mg ionmonomer1770-1990
Assess
Open and closed forms of R1865A human PRP8 RNase H-like domain with bound Mg ionmonomer1771-1990
GOL;CL;
Assess
Open and closed forms of R1865A human PRP8 RNase H-like domain with bound Co ionmonomer1771-1990
CO;CL;
Assess
Open and closed forms of wild-type human PRP8 RNase H-like domain with bound Co ionmonomer1771-1990
CO;GOL;CL;
Assess
Open and closed forms of T1800E human PRP8 RNase H-like domain with bound Mg ionmonomer1771-1990
CL;GOL;
Assess
Open and closed forms of I1790Y human PRP8 RNase H-like domain with bound Mg ionmonomer1770-1989
MG;CL;
Assess
Open and closed forms of T1789P human PRP8 RNase H-like domain with bound Mg ionmonomer1771-1990
Assess
Open and closed forms of mixed T1789P+R1865A and R1865A human PRP8 RNase H-like domain with bound M…monomer1771-1990
Assess
Crystal Structure of PRP8 core domain IVmonomer1771-1989
Assess

6 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5xjc.1.Amonomer0.7925-2335
100.00
Assess
5yzg.1.Amonomer0.7925-2335
IHP;100.00
Assess
5z56.1.Amonomer0.7825-2335
IHP;100.00
Assess
3jb9.1.Amonomer0.7626-2006
74.07
Assess
5zwm.1.Amonomer0.7358-2323
62.62
Assess
6ah0.1.tmonomer0.7156-2335
100.00
Assess